BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 9863179)

  • 1. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036.
    Tapiero H; Yin MB; Catalin J; Paraire M; Deloffre P; Rustum Y; Bizzari JP; Tew KD
    Anticancer Res; 1989; 9(6):1617-22. PubMed ID: 2627116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced bystander effect in response to several chloroethylnitrosoureas: an origin independent of DNA damage?
    Merle P; Morvan D; Caillaud D; Demidem A
    Anticancer Res; 2008; 28(1A):21-7. PubMed ID: 18383820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNA-methyltransferase expression.
    Passagne I; Evrard A; Winum JY; Depeille P; Cuq P; Montero JL; Cupissol D; Vian L
    J Pharmacol Exp Ther; 2003 Nov; 307(2):816-23. PubMed ID: 12970393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
    Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability of a human melanoma cell after single and combined treatment with fotemustine, dacarbazine, and proton irradiation.
    Petrović IM; Korićanac LB; Todorović DV; Ristić-Fira AM; Valastro LM; Privitera G; Cuttone G
    Ann N Y Acad Sci; 2007 Jan; 1095():154-64. PubMed ID: 17404028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling.
    Nikolova T; Roos WP; Krämer OH; Strik HM; Kaina B
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):29-39. PubMed ID: 28143714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focus on Fotemustine.
    De Rossi A; Rossi L; Laudisi A; Sini V; Toppo L; Marchesi F; Tortorelli G; Leti M; Turriziani M; Aquino A; Bonmassar E; De Vecchis L; Torino F
    J Exp Clin Cancer Res; 2006 Dec; 25(4):461-8. PubMed ID: 17310834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic approaches to new nitrosourea development.
    Kohn KW
    Recent Results Cancer Res; 1981; 76():141-52. PubMed ID: 7015427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA damage induced by fotemustine in cultured HL60 cells].
    Shou J; Feng XW
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):474-7. PubMed ID: 9863179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA damage and anticancer effect].
    Kanamaru R; Ishioka C; Konishi Y; Ishikawa S; Shibata H; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):517-23. PubMed ID: 2181939
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.